Published in Exp Hematol on April 01, 1995
Mobilization of peripheral blood 'stem' cells: where there is smoke, is there fire? Exp Hematol (1995) 1.41
Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells. Proc Natl Acad Sci U S A (1996) 1.24
Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med (2001) 5.31
Aortic distensibility in patients with isolated hypercholesterolaemia, coronary artery disease, or cardiac transplant. Lancet (1991) 3.04
The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet (2001) 3.01
Neurodegeneration associated with genetic defects in phospholipase A(2). Neurology (2008) 2.57
Near-infrared flares from accreting gas around the supermassive black hole at the Galactic Centre. Nature (2003) 2.39
Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome. Br J Haematol (2003) 2.36
Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood (1994) 2.10
What's new in blood progenitor cell autotransplants? Bone Marrow Transplant (1994) 1.98
Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation. Leukemia (2003) 1.96
A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. AML Cooperative Study Group. N Engl J Med (1995) 1.94
Ataxia with oculomotor apraxia type 2: clinical, biological and genotype/phenotype correlation study of a cohort of 90 patients. Brain (2009) 1.91
Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. J Clin Oncol (2000) 1.73
Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood (1991) 1.73
Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders. Blood (2001) 1.67
A star in a 15.2-year orbit around the supermassive black hole at the centre of the Milky Way. Nature (2002) 1.56
Study of the apoptosis induced in vitro by antitumoral drugs on leukaemic cells. Leuk Res (1997) 1.50
New insights in biology and current therapeutic options for patients with chronic myelogenous leukemia. Haematologica (1997) 1.47
Antisense oligomers in chronic myeloid leukaemia. Lancet (1993) 1.45
Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Société Française de Greffe de Moelle (SFGM). Bone Marrow Transplant (2000) 1.44
Charon's size and an upper limit on its atmosphere from a stellar occultation. Nature (2006) 1.43
Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur Cytokine Netw (1991) 1.42
A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J Interferon Cytokine Res (1999) 1.38
Allogeneic bone marrow transplantation versus chemotherapy in first-remission acute myeloid leukemia. J Clin Oncol (1989) 1.36
Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia (1997) 1.36
Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983--93 and 1994--8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol (2001) 1.36
Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM). Br J Haematol (1997) 1.33
Allogeneic bone marrow transplantation for low-grade lymphoma. Blood (1998) 1.29
Modalities of synthesis of Ki67 antigen during the stimulation of lymphocytes. Cytometry (1991) 1.29
Large changes in Pluto's atmosphere as revealed by recent stellar occultations. Nature (2003) 1.28
A flow cytometric method using Hoechst 33342 and propidium iodide for simultaneous cell cycle analysis and apoptosis determination in unfixed cells. Cytometry (1994) 1.28
Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch Neurol (2002) 1.26
Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87. Hematol Oncol Clin North Am (2000) 1.22
Follow-up of complete cytogenetic remission in patients with chronic myeloid leukemia after cessation of interferon alfa. J Clin Oncol (2002) 1.18
Intrasinusoidal bone marrow involvement by splenic lymphoma with villous lymphocytes: a helpful immunohistologic feature. Mod Pathol (1997) 1.13
Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation. Br J Haematol (2000) 1.12
In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neutropenic patients. Antimicrob Agents Chemother (1990) 1.11
Allogeneic bone marrow transplantation for acute leukemia in patients over the age of 40 years. Acute Leukemia Working Party of the European Group for Bone Marrow Transplantation (EBMT). Leukemia (1997) 1.10
Expression of neurotrophins and their receptors in human bone marrow. Am J Pathol (1999) 1.08
Overexpression of the heat-shock protein 70 is associated to imatinib resistance in chronic myeloid leukemia. Leukemia (2006) 1.07
IFN-alpha induces autocrine production of IL-6 in myeloma cell lines. J Immunol (1991) 1.05
Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia. J Clin Oncol (1994) 1.05
Homozygosity mapping of Portuguese and Japanese forms of ataxia-oculomotor apraxia to 9p13, and evidence for genetic heterogeneity. Am J Hum Genet (2001) 1.03
Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells. Cytometry (2000) 1.03
Effect of pentoxifylline on apoptosis of cultured cells. J Cardiovasc Pharmacol (1995) 1.01
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10. Leukemia (2011) 1.01
[Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Cancer Radiother (2001) 1.00
Polycythaemia as a complication of transdermal testosterone therapy. Br J Haematol (2000) 1.00
Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute myelogenous leukemia in first remission. Bone Marrow Transplant (1995) 0.99
No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol (2000) 0.99
Homozygosity mapping of a third Joubert syndrome locus to 6q23. J Med Genet (2004) 0.99
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants. Bone Marrow Transplant (2005) 0.98
Novel L2HGDH mutations in 21 patients with L-2-hydroxyglutaric aciduria of Portuguese origin. Hum Mutat (2005) 0.97
Mobilisation of healthy donors with lenograstim and transplantation of HLA-genoidentical blood progenitors in 54 patients with hematological malignancies: a pilot study. Bone Marrow Transplant (1998) 0.97
A comparison of toxicity following two different doses of cyclophosphamide for mobilization of peripheral blood progenitor cells in 116 multiple myeloma patients. Bone Marrow Transplant (2001) 0.96
Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells. Lancet (1999) 0.95
Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission. Eur Cytokine Netw (2000) 0.95
Early transitory rise in intracellular pH leads to Bax conformation change during ceramide-induced apoptosis. Apoptosis (2000) 0.95
Flow cytometry study of human cyclin B1 and cyclin E expression in leukemic cell lines: cell cycle kinetics and cell localization. Exp Cell Res (1999) 0.95
Calcium signalling through nucleotide receptor P2X1 in rat portal vein myocytes. J Physiol (2001) 0.95
Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol (1986) 0.94
Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions. Clin Chem (1999) 0.94
Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood (1992) 0.93
Response at three months is a good predictive factor for newly diagnosed chronic myeloid leukemia patients treated by recombinant interferon-alpha. Blood (1998) 0.93
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia. Leukemia (2008) 0.92
Automated reticulocyte counting and immature reticulocyte fraction measurement. Comparison of ABX PENTRA 120 Retic, Sysmex R-2000, flow cytometry, and manual counts. Am J Clin Pathol (1999) 0.92
Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classification. J Neurol (1990) 0.92
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma. J Clin Oncol (1996) 0.92
Noninvasive continuous positive airway pressure in neutropenic patients with acute respiratory failure requiring intensive care unit admission. Crit Care Med (2000) 0.92
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT). Bone Marrow Transplant (1996) 0.92
Antibiotic susceptibility testing for Chlamydia trachomatis using flow cytometry. Cytometry (1998) 0.90
Caspase activation is an early event in anthracycline-induced apoptosis and allows detection of apoptotic cells before they are ingested by phagocytes. Exp Cell Res (1998) 0.90
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant (1996) 0.89